Like pharmaceutical companies globally - which used to enjoy a preferential exchange...

The USTR has placed India on its "priority watch" list for two years in a row, saying...

It is one of 42 drug-making factories in India that the FDA has banned in recent years

The next hearing on Pfizer's plea is slated for March 21

A notice issued by the Indian Health Ministry at the weekend said that a...

Dinesh Thakur is famous for exposing Ranbaxy safety problems

Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform

US firm Mylan NV received a stern warning from the FDA in August for faulty...

India rejects patent on Pfizer's arthritis drug

Cipla has agreed to buy two generics businesses in the United States in an all-cash...

Indian government has extended price caps to 39 more medicines ranging from commonly...

Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by...

Few drugs in the market are not approved by the authorities and can be life-threatening.

GVK Biosciences is the latest Indian firm to come under international scrutiny over...

Sun Pharma open to large acquisitions post Ranbaxy.

Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India

The new drugs to come under price control include commonly-used antibiotics and...

India's antitrust regulator has approved Sun-Ranbaxy deal, subject to the companies...

Shares in ITC Ltd , India's largest cigarette maker, closed 5.2 per cent lower in a...

Some Indian generic drugmakers are, however, uncertain about the pace of approvals in...